CORINNE WRAY: Open Payments
NPI 1770115115 · GREAT BEND, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $175 · 2025 $665
Food & beverage: $553Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $183 |
| Otsuka America Pharmaceutical, Inc. | 8 | $172 |
| ABBVIE INC. | 4 | $89 |
| Lundbeck LLC | 3 | $63 |
| Alkermes, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: REXULTI, VRAYLAR, ABILIFY MAINTENA, UZEDY, ARISTADA, INGREZZA, Auvelity, Quviviq.
Industry payments across KS — which companies pay providers there.
